Ethnic differences and comorbidities of 909 prurigo nodularis patients
- PMID: 29733939
- PMCID: PMC6518410
- DOI: 10.1016/j.jaad.2018.04.047
Ethnic differences and comorbidities of 909 prurigo nodularis patients
Abstract
Background: Prurigo nodularis (PN) is a poorly understood, understudied pruritic dermatosis that reduces quality of life.
Objective: To characterize the demographics and comorbidities associated with PN.
Methods: Cross-sectional study of patients 18 years and older who were seen at the Johns Hopkins Health System between December 6, 2012, and December 6, 2017.
Results: Over the past 5 years, 909 patients with PN were seen at Johns Hopkins Health System. African American patients were 3.4 times more likely to have PN than white patients were (odds ratio [OR], 3.4; 95% confidence interval [CI], 2.9-3.9; P < .001). A comparison of the study patients and race-matched controls revealed that PN was significantly associated with a variety of systemic, cardiovascular, and psychiatric comorbidities, including chronic kidney disease, chronic hepatitis C, chronic obstructive pulmonary disease, congestive heart failure, depression, and atopic dermatitis. Black patients with PN were 10.5 times more likely (OR, 10.5; 95% CI, 7.9-13.9; P < .001) to have HIV than were race-matched controls with atopic dermatitis, and 8 times more likely (OR, 8.0; 95% CI, 5.7-11.1; P < .001) to have HIV than were African American patients with psoriasis.
Limitations: Our data describe patients seen by 1 hospital system. Our data identify associated conditions and comorbidities but are unable to support a causal relationship.
Conclusion: PN disproportionately affects African Americans and is associated with several systemic conditions, including HIV, chronic kidney disease, and diabetes.
Keywords: HIV; PN; atopic dermatitis; chronic kidney disease; itch; prurigo nodularis; pruritus; psoriasis.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Figures



Comment in
-
Comprehending prurigo nodularis: Ay, there's the rub.J Am Acad Dermatol. 2018 Oct;79(4):636-637. doi: 10.1016/j.jaad.2018.08.001. Epub 2018 Aug 6. J Am Acad Dermatol. 2018. PMID: 30092325 No abstract available.
References
-
- Pereira MP, Steinke S, Zeidler C, et al. European Academy of Dermatology and Venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018. [Epub ahead of print]. - PubMed
-
- Fostini AC, Girolomoni G, Tessari G. Prurigo nodularis: an update on etiopathogenesis and therapy. J Dermatolog Treat. 2013;24(6):458–462. - PubMed
-
- Iking A, Grundmann S, Chatzigeorgakidis E, Phan NQ, Klein D, St €ander S. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013;27(5):550–557. - PubMed
-
- Winhoven SM, Gawkrodger DJ. Nodular prurigo: metabolic diseases are a common association. Clin Exp Dermatol. 2007; 32(2):224–225. - PubMed
-
- US Centers for Medicare and Medicaid Services. Chronic conditions. Available at: https://www.cms.gov/ResearchStatistics-Data-and-Systems/Statistics-Trend.... Accessed December 27, 2017.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous